Tag archive for ‘Uplizna’
MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Monday, February 1st, 2021
0 Comments

Horizon Therapeutics to acquire Viela Bio for $3bn to grow rare disease portfolio

Horizon Therapeutics, an Irish biopharma company, has agreed to acquire Viela Bio, a US-based biotech company, for $53 per share in cash or about $3.05 billion in a move to significantly expand its development pipeline More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Friday, June 12th, 2020
0 Comments

US biotech company Viela Bio bags Uplizna FDA approval for NMOSD

Uplizna FDA approval : US biotech company Viela Bio has secured approval from the US Food and Drug Administration (FDA) for Uplizna (inebilizumab-cdon) injection for intravenous use for the treatment of neuromyelitis More...